Futura Medical PLC Liberum Appointed as Nominated Adviser & Broker (9076Z)
23 Mayo 2019 - 1:01AM
UK Regulatory
TIDMFUM
RNS Number : 9076Z
Futura Medical PLC
23 May 2019
Futura Medical
Appointment of Liberum as Nominated Adviser and Broker
23 May 2019
Futura Medical plc (AIM: FUM), a pharmaceutical company
developing a portfolio of innovative products for sexual health and
pain relief, today announces the appointment, with immediate
effect, of Liberum Capital Limited ("Liberum") as its Nominated
Adviser and sole Broker.
ENDS
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
Email: Investor.relations@futuramedical.com
Tel: +44 (0) 1483 685 670
Nominated Adviser and Broker:
Liberum
Bidhi Bhoma
Euan Brown
Kane Collings
Tel: +44 (0) 20 3100 2000
For media enquiries please contact:
Optimum Strategic Communications
Mary Clark/ Hollie Vile/ Ellie Blackwell
Email: futuramedical@optimumcomms.com
Tel: +44 (0) 203 950 9144
Notes to editors
About Futura Medical plc
Futura Medical plc (AIM: FUM), is a pharmaceutical company
developing a portfolio of innovative products based on its
proprietary, transdermal DermaSys(R) drug delivery technology.
These products are optimised for clinical efficacy, safety,
administration and patient convenience and are developed for the
prescription and consumer healthcare markets as appropriate.
Current therapeutic areas are sexual health, including erectile
dysfunction, and pain relief. Development and commercialisation
strategies are designed to maximise product differentiation and
value creation whilst minimising risk.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
APPQLLFLKEFFBBK
(END) Dow Jones Newswires
May 23, 2019 02:01 ET (06:01 GMT)
Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024